Johns Hopkins Diabetes Guide
Fibric Acid Derivatives
INDICATIONS
FDA
FDA
- Primary hypercholesterolemia or mixed dyslipidemia: To reduce LDL, total cholesterol, and triglycerides.
- Hypertriglyceridemia: Adjunct to diet treatment and improved glycemic control in patients with diabetes.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Prevention of acute pancreatitis secondary to severe hypertriglyceridemia
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: January 7, 2018
Citation
Crowder, Alona, and Simeon Margolis. "Fibric Acid Derivatives." Johns Hopkins Diabetes Guide, 2018. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547053/all/Fibric_Acid_Derivatives.
Crowder A, Margolis S. Fibric Acid Derivatives. Johns Hopkins Diabetes Guide. 2018. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547053/all/Fibric_Acid_Derivatives. Accessed May 30, 2023.
Crowder, A., & Margolis, S. (2018). Fibric Acid Derivatives. In Johns Hopkins Diabetes Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547053/all/Fibric_Acid_Derivatives
Crowder A, Margolis S. Fibric Acid Derivatives [Internet]. In: Johns Hopkins Diabetes Guide. ; 2018. [cited 2023 May 30]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547053/all/Fibric_Acid_Derivatives.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Fibric Acid Derivatives
ID - 547053
A1 - Crowder,Alona,PharmD
AU - Margolis,Simeon,M.D.
Y1 - 2018/01/07/
BT - Johns Hopkins Diabetes Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547053/all/Fibric_Acid_Derivatives
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
